The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2015

Filed:

Nov. 04, 2011
Applicants:

William L. Warren, Orlando, FL (US);

Donald Drake, Iii, Orlando, FL (US);

Janice Moser, Orlando, FL (US);

Inderpal Singh, Orlando, FL (US);

Haifeng Song, Oviedo, FL (US);

Eric Mishkin, Winter Springs, FL (US);

John G. Tew, Mechanicsville, VA (US);

Inventors:

William L. Warren, Orlando, FL (US);

Donald Drake, III, Orlando, FL (US);

Janice Moser, Orlando, FL (US);

Inderpal Singh, Orlando, FL (US);

Haifeng Song, Oviedo, FL (US);

Eric Mishkin, Winter Springs, FL (US);

John G. Tew, Mechanicsville, VA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); G01N 33/50 (2006.01); C12N 5/0781 (2010.01); C12N 5/0783 (2010.01); C12N 5/0784 (2010.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
G01N 33/5052 (2013.01); C12N 5/0635 (2013.01); C12N 5/0636 (2013.01); C12N 5/0639 (2013.01); C12N 5/0697 (2013.01); G01N 33/505 (2013.01); G01N 33/5088 (2013.01); C12N 2500/90 (2013.01); C12N 2501/21 (2013.01); C12N 2502/1107 (2013.01); C12N 2502/1114 (2013.01); C12N 2502/1121 (2013.01); C12N 2502/28 (2013.01); C12N 2503/04 (2013.01); C12N 2510/04 (2013.01); C12N 2531/00 (2013.01); C12N 2533/50 (2013.01); C12N 2533/54 (2013.01); C12N 2535/10 (2013.01);
Abstract

The present invention relates to methods for preparing an artificial immune system. The artificial immune system comprises a cell culture comprising T cells, B cells and antigen-primed dendritic cells. The artificial immune system of the present invention can be used for in vitro testing of vaccines, adjuvants, immunotherapy candidates, cosmetics, drugs, biologics and other chemicals.


Find Patent Forward Citations

Loading…